Back to News
Market Impact: 0.2
Marathon Fusion Publishes New Pathway for Scalable Production of Promising Cancer-Treatment Isotope Terbium-149
Source: PR Newswire
Healthcare & BiotechTechnology & InnovationProduct Launches
Marathon Fusion announced research proposing a stable gadolinium precursor that could resolve a decades-old isotope-supply bottleneck for producing terbium-149 (Tb-149). The approach could enable Tb-149 production using widely available medical cyclotrons, potentially broadening access to the medical isotope, though the announcement provides no commercialization timeline or financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
More News
- Trump Versus Xi: How Their High-Stakes Summits Compare
- Trump, Xi Address AI, Taiwan During State Visit
- Oracle Japan shares surge 7% after record fiscal first quarter, bucking selloff of U.S. parent
- China's Xi urges U.S. to cooperate on AI
- Akamai secures $11.6B cloud deal with Anthropic for AI workloads
- U.S. government seeks to join Elon Musk in challenge against EU's fine on X